Live feed
Filing
SC 13D/A
SC 13D/A0001144204-18-009568·RA CAPITAL MANAGEMENT, L.P.
Schedule 13D ownership disclosure
Ra Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 74933V108
Event date: 2018-02-14
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,135,084
- Percent of class
- 10.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-18-009568
- Form type
- SC 13D/A
- Filer
- RA CAPITAL MANAGEMENT, L.P.
- CIK
- CIK 1346824
- Filed
- Feb 16, 2018
- Reporting period
- Feb 14, 2018
- Description
- Schedule 13D beneficial ownership